Results 51 to 60 of about 311 (111)

Plain language summary for the manuscript: Comparing the efficacy and safety of weekly somatrogon with daily somatropin to treat children with growth hormone deficiency

, 2022
This is a plain language summary (PLS) of an article published in a peer-reviewed scientific journal. This PLS is not peer-reviewed. The publisher of the original manuscript was not involved in the preparation of this PLS and has neither reviewed nor ...
Lawrence A. Silverman (11874445), Carl L. Roland (836293), Aleksandra Pastrak (11874458), Joel Steelman (11874443), CheolWoo Ko (11874448), Renata Stawerska (6574376), Ho-Seong Kim (286495), Srinivas Rao Valluri (14173420), Elpis Vlachopapadopoulou (9372585), Cheri Deal (14173412), Moshe Phillip (809163), Oleg Malievskiy (11874449), Jose F. Cara (14173417), Carrie Turich Taylor (14172136), Michael P. Wajnrajch (12336145), Bradley S. Miller (12162545)   +15 more
core   +1 more source

Issue Information

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 2, Page 193-196, February 2025.
wiley   +1 more source

Facts and news about growth hormone replacement therapy in adults

International audienceAdult growth hormone deficiency (GHD) is associated with increased adiposity, reduced lean mass, adverse lipid profile, decreased bone density and impaired quality of life.
Brue, Thierry, Aouchiche, Karine, Piazzola, Cécilia, Castinetti, Frédéric, Morange, Isabelle, Vermalle, Marie, Albarel, Frédérique, Sahakian, Nicolas, Cuny, Thomas   +8 more
core   +1 more source

Long-acting growth hormone in the treatment of children with growth hormone deficiency

IntroductionThe introduction of long-acting formulations in recent years is changing the landscape of growth hormone (GH) therapy. Daily recombinant human GH (rhGH) has been the treatment of choice for children and adults with GH deficiency (GHD), since ...
Insalaco, Anna, Iughetti, Lorenzo, Predieri, Barbara, Lucaccioni, Laura   +3 more
core   +1 more source

Long-Acting GH: a new frontier in growth hormone therapy. Experience of efficacy and safety in the treatment of 30 pediatric patients

reservedBackground: La recente disponibilità in commercio di molecole di Ormone della crescita Long-Acting (LAGH) rappresenta un promettente nuovo approccio terapeutico nei soggetti con deficit di GH.
PERRONE, VIVIANA
core  

New drug: Somatrogon for growth hormone deficiency

Australian Prescriber, 2022
openaire   +3 more sources

Weekly somatrogon vs daily somatropin: a propensity score-matched analysis of growth outcomes from clinical data vs KIGS. [PDF]

J Endocr Soc
Deal CL, Maghnie M, Wang R, Carlsson MO, Wajnrajch MP, Silverman LA, Polak M, La Torre D, Cara JF, Miller BS.   +9 more
europepmc   +1 more source

The efficacy and safety of weekly somatrogon treatment in turkish children with growth hormone deficiency: a real-world cohort study. [PDF]

Endocrine
Gider T, Unal E, Yel S, Kolbaşı B, Düzgün H.   +4 more
europepmc   +1 more source

Can long-acting growth hormone improve adherence in pediatric growth hormone deficiency? [PDF]

Endocrine
Rodaro C, Tamaro G, Fachin A, Nicolardi F, Tommasi S, Tornese G.   +5 more
europepmc   +1 more source

Somatrogon recommended for growth disturbance in children

, 2023

core   +1 more source